Yan Min Tang
Director/Board Member chez SINOCELLTECH GROUP LIMITED
Profil
Yan Min Tang currently works at Sinocelltech Group Ltd., as Director from 2017, Sino Biological Inc., as Director from 2018, Beijing Jiakesi New Drug Development Co. Ltd., as Director from 2018, Jacobio Pharmaceuticals Group Co., Ltd., as Non-Executive Director from 2018, Jacobio Hk Pharmaceuticals Co. Ltd., as Director from 2018, Beijing Sinotau Pharmaceutical Technology Co., Ltd., as President & Director from 2016, Suzhou Cure Genetics Co., Ltd., as Director from 2018, Suzhou Keyue Biotech Co. Ltd., as Director from 2018, Abbisko Cayman Ltd., as Non-Executive Director from 2021, Guangdong Xiantong Molecular Imaging Technology Co. Ltd., as Director from 2020, Qiming Venture Partners Ltd., as Venture Partner, Beijing Shenogen Pharma Group Ltd., as Member-Supervisory Board from 2019, Sinotau Pharmaceuticals Group, as President, and Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP, as Investment Partner from 2015.
Ms. Tang also formerly worked at Shenogen Pharma Group Ltd., as Director in 2019 and Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd., as General Manager from 2002 to 2015.
Ms. Tang received her Masters Business Admin degree in 2008 from Cheung Kong Graduate School of Business and undergraduate degree in 1996 from Shenyang Pharmaceutical University.
Postes actifs de Yan Min Tang
| Sociétés | Poste | Début |
|---|---|---|
| SINOCELLTECH GROUP LIMITED | Director/Board Member | 12/07/2017 |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 22/08/2018 |
| ABBISKO CAYMAN LIMITED | Director/Board Member | 10/06/2021 |
| SINO BIOLOGICAL,INC. | Director/Board Member | 01/04/2018 |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
 Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a private company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | President | 01/05/2016 |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Private Equity Investor | - |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | Director/Board Member | 01/09/2020 |
| Suzhou Keyue Biotech Co. Ltd. | Director/Board Member | 01/10/2018 |
Suzhou Cure Genetics Co., Ltd.
 Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Director/Board Member | 01/07/2018 |
| ░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Yan Min Tang
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Yan Min Tang
| Cheung Kong Graduate School of Business | Masters Business Admin |
| Shenyang Pharmaceutical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SINOCELLTECH GROUP LIMITED | Commercial Services |
| SINO BIOLOGICAL,INC. | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| Entreprise privées | 12 |
|---|---|
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Finance |
Shenogen Pharma Group Ltd.
 Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Health Technology |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Health Technology |
Sinotau Pharmaceuticals Group
 Sinotau Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Sinotau Pharmaceuticals Group is a Chinese pharmaceutical company founded in 2005 that focuses on becoming an overall solution provider in the field of neurological degenerative lesions. The company is based in Beijing, China, and has subsidiaries in China. The company offers a range of products and services, including nuclear medicine, radioactive drug development, high-quality production, and clinical academic promotion. The company has a drug research and development technology platform and monoclonal antibody research and development drug technology platform, supplemented by generic drug research and development, production, and sales. The company also offers targeted drugs, precise diagnosis, and precision therapy drugs guided by research, development, and commercial molecular images. | Health Technology |
| Jacobio Hk Pharmaceuticals Co. Ltd. | |
| Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd. | |
| Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP | |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a private company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | Commercial Services |
Suzhou Cure Genetics Co., Ltd.
Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Health Technology |
| Suzhou Keyue Biotech Co. Ltd. | |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. |
